News 11.03.2025 Schlieren (Zurich), Switzerland, March 11, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial and operational results for the full year 2024, marking another year of record growth, increased market penetration, and strategic portfolio advancements. Revenue from Direct MagnetOs...
News 07.03.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ("Molecular Partners" or the "Company"), today announced its...
Events, External events
Event date: 17.04.2025
How bio-based innovation can achieve planetary health
More information and registration: https://bioeconomy-hub-japan.com/en/index.html
Events, Internal events
Event date: 04.03.2025
Lunch & Learn with WuXi AppTec
Come join us for an informative lunch event at the Superlab Zürich Schlieren! WuXi AppTec Experts will be sharing their expertise and insights to accelerate new drug discovery, so don’t miss out on this great opportunity to expand your knowledge.
Lunch will be provided, so all...
News 18.02.2025 Schlieren (Zurich), February 17, 2025 – LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the first participants have been vaccinated in a Phase 1 controlled study of its multivalent vaccine candidate, LBT-SA7. The candidate is designed to prevent skin and...